Авторы

  • Ashurova Nigora Gafurovna

Биография автора

  • Ashurova Nigora Gafurovna

    Bukhara State Medical Institute named after Abu Ali ibn Sino, Department of "Obstetrics and Gynecology in Family Medicine", Bukhara, Uzbekistan

DOI:

https://doi.org/10.71337/inlibrary.uz.tbir.100168

Ключевые слова:

Keywords: stress-induced hyperprolactinemia premenstrual tension syndrome menopausal disorders

Аннотация

Abstract: The article examines contemporary aspects of stress-related diseases affecting the female reproductive system. It highlights that young women today experience the highest levels of stress, leading to conditions such as ovarian dysfunction, premenstrual tension syndrome, and benign mammary gland dysplasia. The mechanisms underlying these pathologies are discussed. Additionally, the article explores the effectiveness of long-term non-hormonal therapy using a standardized extract from Vitex agnus-castus (Ze440). It also considers the potential of a safe non-hormonal treatment for early menopausal symptoms based on Cimicifuga racemosa extract (Ze450), which aligns with treatment strategies for women experiencing menopausal disorders.


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

432

STRESS AS A FACTOR AFFECTING THE FUNCTIONING OF THE

WOMEN'S REPRODUCTIVE SYSTEM

Ashurova Nigora Gafurovna

Bukhara State Medical Institute named after Abu Ali ibn Sino, Department

of "Obstetrics and Gynecology in Family Medicine", Bukhara, Uzbekistan

Abstract: The article examines contemporary aspects of stress-related

diseases affecting the female reproductive system. It highlights that young women

today experience the highest levels of stress, leading to conditions such as ovarian

dysfunction, premenstrual tension syndrome, and benign mammary gland

dysplasia. The mechanisms underlying these pathologies are discussed.

Additionally, the article explores the effectiveness of long-term non-hormonal

therapy using a standardized extract from Vitex agnus-castus (Ze440). It also

considers the potential of a safe non-hormonal treatment for early menopausal

symptoms based on Cimicifuga racemosa extract (Ze450), which aligns with

treatment strategies for women experiencing menopausal disorders.

Keywords: stress-induced hyperprolactinemia, premenstrual tension

syndrome, menopausal disorders

Introduction :

Stress is a complex phenomenon that can have both beneficial and harmful

effects on the human div. In some cases, it serves as a powerful motivator,

inspiring personal growth, driving goal achievement, and encouraging problem-

solving. During such moments, we experience an energy boost, work with greater

efficiency, and ultimately achieve success. This type of stress, known as eustress,

is considered positive.


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

433

However, stress often becomes a source of anxiety and negative emotions,

forcing the div into an emergency state. In such cases, it can negatively impact

health by disrupting sleep, increasing heart rate, altering breathing patterns, and

raising blood pressure. This harmful form of stress, referred to as distress, can have

serious consequences for both physical and mental well-being.

The causes of stress vary widely and depend on an individual's characteristics

and responses. Stress reactions can be triggered by both external and internal

factors.

External factors contributing to stress include everyday challenges such as

traffic congestion, long lines in stores, and conflicts at work or within the family.

Financial difficulties, such as job loss, lack of funds, or debt, also play a significant

role. Additionally, social factors like low self-confidence, fear of judgment, and

failures in social interactions can contribute to stress. Broader issues, such as

political and economic instability, wars, natural disasters, pandemics, and financial

crises, further exacerbate stress levels.

Internal factors, on the other hand, stem from an individual's personality traits

and upbringing. These include negative thought patterns, such as over-focusing on

problems, exaggerating the significance of events, or excessive worry about the

future. Low self-esteem, fear of failure, and difficulty in asserting oneself can also

contribute to stress. Perfectionism—characterized by an unrelenting pursuit of

excellence, intolerance of mistakes, and an inability to relax—can be another

internal stressor. Additionally, dissatisfaction with life, whether due to a lack of

personal goals, an unfulfilling job, or unhealthy relationships, can further amplify

stress.

The way an individual perceives and responds to stress determines whether its

effects will be positive or negative.

The Impact of Stress on the Female Reproductive System


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

434

Research indicates that women experience higher levels of stress compared to

men. Over the past five years, 43% of women have reported increased stress levels,

in contrast to 33% of men. This trend is further supported by a 10-point stress scale

assessment, where women, on average, rate their stress level at 5.3, while men

report a lower average of 4.6.

It is important to recognize that stress is not merely an abstract concept but a

physiological response to external stimuli. It triggers a cascade of neuroendocrine

changes that affect mental, physiological, and biochemical processes in the div.

In response to stress, the div releases hormones such as cortisol, adrenaline, and

norepinephrine, which prepare it to react in threatening situations. However, when

stress becomes chronic, its impact can be detrimental, particularly to the female

reproductive system.

Chronic stress can disrupt the hypothalamic-pituitary-ovarian axis (HPO

axis)—a key regulatory system controlling the menstrual cycle. The HPO axis

functions as follows: the hypothalamus, located in the brain, produces

gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to

release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These

hormones then act on the ovaries, regulating egg maturation and the production of

female sex hormones—estrogen and progesterone.

Chronic stress can disrupt this delicate system at multiple levels. Stress

hormones, particularly cortisol, suppress GnRH secretion in the hypothalamus,

leading to decreased production of LH and FSH. As a result, menstrual cycle

irregularities, anovulation (lack of ovulation), infertility, and other reproductive

health issues may occur.

In addition to hormonal disruption, stress also weakens the immune system,

making the div more susceptible to infections and inflammation. Prolonged stress

increases the risk of developing autoimmune disorders such as endometriosis,


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

435

rheumatoid arthritis, and multiple sclerosis, all of which can negatively impact

reproductive health.

Menstrual Cycle Disorders in Young Women – "Metropolis Syndrome"

Menstrual cycle irregularities are classified as ovarian dysfunction (E28)

according to the International Classification of Diseases, 10th Revision (ICD-10).

One of the contributing factors to ovarian dysfunction is sleep disturbances, which

are particularly common among residents of large cities due to excessive light

pollution and chronic stress exposure. As a result, sleep disorders are considered

part of the so-called "metropolis syndrome."

For many women, the fast-paced urban lifestyle has a dual impact. On one

hand, it offers comfort, cutting-edge technology, and opportunities for personal and

career growth. On the other hand, it brings environmental challenges, poor dietary

habits, sleep disruptions, circadian rhythm disturbances, and psychological

changes such as stress, depression, and aggression, all of which negatively affect

reproductive health. Studies show that menstrual irregularities occur 1.5 times less

frequently in rural women compared to their urban counterparts. This may be

attributed to "metropolis syndrome," where urban dwellers are more exposed to

environmental stressors, leading to circadian rhythm disruptions and reduced

melatonin production.

Melatonin is synthesized at night in a cyclical pattern regulated by the day-

night cycle. Research has shown that Vitex agnus-castus (chaste tree) fruit extract

enhances melatonin secretion in a dose-dependent manner, indicating its beneficial

effects on sleep disturbances associated with menstrual cycle irregularities.

A double-blind, placebo-controlled study involving reproductive-aged

women with premenstrual syndrome (PMS) symptoms demonstrated that taking 20

mg of standardized Vitex agnus-castus extract (Prefemin, Amaxa Ltd, UK) for

three months led to a statistically significant reduction in PMS symptoms,

including menstrual cycle normalization. In contrast, a lower dose (8 mg) had only


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

436

minor effects comparable to placebo, while a higher dose (30 mg) did not provide

any additional significant benefits over the 20 mg dose.

Premenstrual Tension Syndrome – A Modern Women's Life Aspect

Premenstrual Tension Syndrome (classified as N94.3 in the International

Classification of Diseases, 10th Revision - ICD-10) is defined as recurring

physical, cognitive, behavioral, and mood changes occurring in the premenstrual

phase. Approximately 90% of women report experiencing some symptoms

associated with premenstrual tension syndrome, which negatively impact their

daily functioning and are commonly referred to as premenstrual syndrome (PMS)

[17].

The diagnostic criteria for premenstrual tension syndrome were established in

2000 by the American College of Obstetricians and Gynecologists (ACOG) [18].

According to these criteria, the presence of at least one physical (such as bloating,

breast tenderness/swelling, swelling of the lower limbs, headaches) or

psychological (such as irritability, mood swings, episodes of anger, depression,

emotional instability, difficulties in personal or social life) symptom that appears

five days before menstruation and resolves within four days after its onset,

occurring in at least three consecutive cycles without the use of medication,

indicates a diagnosis of premenstrual tension syndrome [18].

Benign Breast Dysplasia – A Leading Condition in Women's Reproductive

Health

In 1981, the World Health Organization (WHO) introduced the term “breast

dysplasia / fibrocystic disease”, defining it as a condition characterized by a wide

range of proliferative and regressive changes in breast tissue, with an altered ratio

of epithelial and connective tissue components . In the International Classification

of Diseases, 10th Revision (ICD-10), this condition is classified as “benign breast

dysplasia” (N60). The terms "benign breast dysplasia" and "fibrocystic disease" are

synonymous, referring to a group of breast disorders caused by an imbalance


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

437

between epithelial and connective tissue components, leading to localized or

diffuse proliferative and regressive changes with varying clinical manifestations.

Since the breasts are part of the reproductive system, their diagnosis and

treatment are closely linked to assessing and addressing changes in reproductive

organs. Sex hormones play a crucial role in the development of breast conditions,

making hormonal imbalance a key factor in the progression of these disorders.

Identifying and treating benign breast diseases is an essential step in breast cancer

prevention, as early intervention can help manage risks and maintain breast health.

Fetal Growth in an Adverse Intrauterine Environment and Fetal

Programming

Experimental and clinical studies suggest that early-life stress can cause long-

lasting changes in gene expression due to epigenetic modifications, leading to

various metabolic and neurodevelopmental disorders. Research indicates that low

birth weight is associated with an increased risk of metabolic syndrome and

vascular diseases in adulthood, likely due to alterations in key hormonal pathways

that regulate growth and development.

Stress is characterized as a disruption of homeostasis, and it is proposed that

the fetus may respond to adverse intrauterine conditions by increasing placental

CRH levels. As a result, abnormal trophoblast invasion, inadequate remodeling of

spiral arteries, and high-resistance placental blood vessels can contribute to

placental dysfunction, representing a state of compromised homeostasis. Such

intrauterine stressors can lead to elevated placental CRH levels, increasing the risk

of obstetric complications such as preeclampsia, intrauterine growth restriction

(IUGR), and preterm birth.

Furthermore, excessive fetal cortisol levels can play a critical role in growth

restriction and contribute to fetal programming, which links prenatal stress to long-

term health outcomes. Elevated fetal cortisol may impair normal fetal growth and

increase susceptibility to diseases in later life, including cardiovascular conditions


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

438

and insulin resistance. The hypothalamic-pituitary-adrenal (HPA) axis, which

regulates stress responses, is particularly vulnerable to programming during fetal

development.

Impact of Prenatal Stress on HPA Axis Programming and Long-Term

Health.

Experimental studies in pregnant rats have demonstrated that exposure to

various stressors, such as a low-protein diet and physical restraint, can lead to

increased corticosteroid secretion later in life. Similarly, in humans, low birth

weight—an indicator of prenatal stress—is linked to elevated plasma cortisol

levels, dysregulated HPA axis function, and heightened cortisol responses to

psychological stress. These physiological adaptations, triggered by adverse

prenatal conditions, support fetal survival by restricting growth but may increase

the risk of metabolic diseases if the postnatal environment is relatively stable.

The extent to which early environmental factors influence HPA axis

programming depends on the timing and severity of intrauterine stress. A cross-

sectional study involving 68 boys and 72 girls suggested that prenatal stressors not

only contribute to low birth weight but also have long-term effects on stress

responses, with male newborns displaying altered adrenocortical reactivity to stress

and females exhibiting changes in baseline adrenocortical activity. This suggests

that HPA axis programming may be gender-specific. Additionally, recent

epidemiological data indicate that preterm birth is associated with reduced long-

term survival and reproductive potential.

Hyperprolactinemia in Menopausal Women

Elevated prolactin levels under stress are not only common in younger women

but also in those of menopausal age. The risk of developing breast cancer increases

with age , despite the decline in estrogen levels in a woman's div. Prolactin can

act as a catalyst for breast cancer development by inducing cell proliferation and

inhibiting apoptosis.


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

439

Additionally, prolactin stimulates metabolic processes in breast tissues and,

importantly, enhances the sensitivity of breast receptors to estradiol, leading to an

increase in estrogen receptor density. As a result, hyperprolactinemia often causes

excessive estrogenic influence on target organs, outweighing the effects of

progesterone, which may contribute to hormonal imbalances and an increased risk

of estrogen-dependent conditions.

The Role of Maternal Stress in Fetal Development

Both experimental and clinical studies have linked prenatal maternal stress—

defined as stressful experiences during pregnancy—to adverse birth outcomes such

as preterm birth and low birth weight, as well as an increased risk of long-term

diseases in offspring. Elevated maternal glucocorticoid levels and maternal

exposure to glucocorticoids have been associated with intrauterine growth

restriction (IUGR), insulin resistance, and persistent dysregulation of the

hypothalamic-pituitary-adrenal (HPA) axis in the child.

While

maternal

corticotropin-releasing

hormone

(CRH)

and

adrenocorticotropic hormone (ACTH) do not cross the placenta, maternal

glucocorticoids can, making them a primary factor in transmitting prenatal stress

to the fetus. The enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) in

the placenta serves as a protective barrier by converting active cortisol into its

inactive form, cortisone. However, elevated maternal glucocorticoid levels or

decreased 11β-HSD2 activity can increase fetal exposure to glucocorticoids,

potentially disrupting normal development.

Research in both animals and humans suggests that various prenatal

stressors—including maternal anxiety, relationship conflicts, and even large-scale

events like natural disasters—can elevate the risk of metabolic and

neurodevelopmental disorders in offspring. These may include insulin resistance,

type 2 diabetes, cardiovascular disease, impaired cognitive function, behavioral

disorders, autism, and schizophrenia. Additionally, maternal depression, anxiety,


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

440

stress, and poor diet during pregnancy have been strongly linked to low birth

weight, preterm birth, and insulin resistance in children.

Conclusion:

Women’s reproductive health is a complex and delicate system, highly

responsive to various negative factors, including both acute and chronic stress. As

a common aspect of modern life, stress can negatively impact health and quality of

life, manifesting as ovarian dysfunction, premenstrual syndrome (PMS), and

benign breast dysplasia.

To mitigate the effects of stress on reproductive health, the use of Prefemin

(Amaxa Ltd, UK) is recommended. This standardized extract of Vitex agnus-castus

(Ze440) demonstrates dose-dependent effectiveness, with optimal therapeutic

benefits at a daily dose of 20 mg. Based on clinical trials, the European Medicines

Agency has classified Ze440 (Prefemin, Amaxa Ltd, UK) under the status of “well-

established medicinal use” for the comprehensive treatment of menstrual cycle

disorders. Long-term use has shown that a once-daily tablet is well-tolerated, with

minimal risk of side effects.

Menopause marks a significant transition in a woman's life, requiring an

individualized medical approach to preserve physical, emotional, and overall

quality of life. The management of early menopausal symptoms with the non-

hormonal, effective, and safe medication Cimicifuga forte (Amaxa Ltd, UK) is

recommended to alleviate vasomotor symptoms, prevent weight gain, and reduce

insulin resistance.

References:

1.

Chrousos, G.P. & P.W. Gold. 1992. The concepts of stress and

stress system disorders. Overview of physical and behavioral

homeostasis. JAMA 267: 1244–1252.

2.

Kalantaridou, S.N., E. Zoumakis, A. Makrigiannakis, et al.

2010. Corticotropin-releasing hormone, stress and human


background image

https://scientific-jl.com/luch/

Часть-41_ Том-2_ Март-2025

441

reproduction: an update. J. Reprod. Immunol.

85: 33–38

3.

Chrousos, G.P. & P.W. Gold. 1992. The concepts of stress and

stress system disorders. Overview of physical and behavioral

homeostasis. JAMA 267: 1244–1252.

4.

Tsvetkova E. The importance of melatonin in the regulation of

metabolism, eating behavior, sleep, and the prospects for the use of

melatonin drugs for obesity treatment. Obesity and metabolism.

2021;18(2):112–124. Available at: https://doi.org/10.14341/omet12279

(in Russian)

5.

Dongju S. Limbic response to stress linking life trauma and

hypothalamus-pituitary-adrenal axis function. Psychoneuroendocrinology.

2019;99:38–46. doi: 10.1016/j.psyneuen.2018.08.023

6.

Samara

L.

Stress-Induced

Hyperprolactinemia:

Pathophysiology

and

Clinical

Approach.

Obstet

Gynecol

Int.

2018;3:2018:9253083. doi: 10.1155/2018/9253083

7.

Lynch CD, Sundaram R, Maisog JM, Sweeney AM, Buck Louis

GM. Preconception stress increases the risk of infertility: results from a

couple-based prospective cohort study--the LIFE study. Hum Reprod.

2014;29:1067-75.

8.

Wesselink AK, Hatch EE, Rothman KJ, et al. Perceived stress

and fecundability: a preconception cohort study of North American cou ples.

Am J Epidemiol. 2018;187:2662-71.

9.

Smith SM, Vale WW. The role of hypothalamic-pituitary-

adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci.

2006;8:383-95.

10.

Carrasco GA, Van de Kar LD. Neuroendocrine pharmacology

of stress. Eur J Pharmacol. 2003;463:235-72.